RXMD vs SSY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXMD is a Hold and SSY is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RXMD’s FA Score shows that 1 FA rating(s) are green whileSSY’s FA Score has 0 green FA rating(s).
- RXMD’s FA Score: 1 green, 4 red.
- SSY’s FA Score: 0 green, 5 red.
Price Growth
RXMD (@Drugstore Chains) experienced а 0.00% price change this week, while SSY (@Drugstore Chains) price change was -0.88% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +1.03%. For the same industry, the average monthly price growth was +3.68%, and the average quarterly price growth was +3.61%.
Reported Earning Dates
RXMD is expected to report earnings on Aug 15, 2023.
SSY is expected to report earnings on Nov 14, 2024.
Industries' Descriptions
@Drugstore Chains (+1.03% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
| RXMD | SSY | RXMD / SSY | |
| Capitalization | 19.7M | 5.14M | 383% |
| EBITDA | -8.77M | -3.03M | 289% |
| Gain YTD | -32.803 | -14.731 | 223% |
| P/E Ratio | 80.00 | 1.36 | 5,899% |
| Revenue | 10.1M | 46.9M | 22% |
| Total Cash | 2.23M | 2.06M | 108% |
| Total Debt | 3.01M | 663K | 453% |
RXMD | SSY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 46 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 96 | |
PRICE GROWTH RATING 1..100 | 56 | 42 | |
P/E GROWTH RATING 1..100 | 18 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SSY's Valuation (51) in the Hospital Or Nursing Management industry is in the same range as RXMD (78) in the null industry. This means that SSY’s stock grew similarly to RXMD’s over the last 12 months.
SSY's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as RXMD (100) in the null industry. This means that SSY’s stock grew similarly to RXMD’s over the last 12 months.
SSY's SMR Rating (96) in the Hospital Or Nursing Management industry is in the same range as RXMD (97) in the null industry. This means that SSY’s stock grew similarly to RXMD’s over the last 12 months.
SSY's Price Growth Rating (42) in the Hospital Or Nursing Management industry is in the same range as RXMD (56) in the null industry. This means that SSY’s stock grew similarly to RXMD’s over the last 12 months.
RXMD's P/E Growth Rating (18) in the null industry is significantly better than the same rating for SSY (100) in the Hospital Or Nursing Management industry. This means that RXMD’s stock grew significantly faster than SSY’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
RXMD and
Correlation & Price change
A.I.dvisor tells us that RXMD and PETS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RXMD and PETS's prices will move in lockstep.
| Ticker / NAME | Correlation To RXMD | 1D Price Change % | ||
|---|---|---|---|---|
| RXMD | 100% | N/A | ||
| PETS - RXMD | 10% Poorly correlated | +35.78% | ||
| HITI - RXMD | 9% Poorly correlated | +2.26% | ||
| WBA - RXMD | 5% Poorly correlated | +0.43% | ||
| SSY - RXMD | 4% Poorly correlated | -8.35% | ||
| SAEYY - RXMD | 4% Poorly correlated | N/A | ||
More | ||||
SSY and
Correlation & Price change
A.I.dvisor tells us that SSY and HITI have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSY and HITI's prices will move in lockstep.
| Ticker / NAME | Correlation To SSY | 1D Price Change % | ||
|---|---|---|---|---|
| SSY | 100% | -8.35% | ||
| HITI - SSY | 8% Poorly correlated | +2.26% | ||
| LFLY - SSY | 6% Poorly correlated | +6.43% | ||
| ALBHF - SSY | 5% Poorly correlated | +7.91% | ||
| RXMD - SSY | 4% Poorly correlated | N/A | ||
| YI - SSY | -0% Poorly correlated | +8.42% | ||
More | ||||